Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 6.7% – Here’s What Happened
by Doug Wharley · The Cerbat GemMosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) dropped 6.7% during trading on Friday . The company traded as low as $0.3318 and last traded at $0.6950. Approximately 2,722 shares changed hands during trading, an increase of 759% from the average daily volume of 317 shares. The stock had previously closed at $0.7450.
Mosaic ImmunoEngineering Trading Down 6.7%
The stock has a market capitalization of $5.03 million, a price-to-earnings ratio of -7.72 and a beta of -0.78. The stock has a 50-day simple moving average of $0.57 and a 200 day simple moving average of $0.58.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.